AbbVie Inc. is 17.3x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($399.47 B vs $23.10 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | UTHR | ABBV |
|---|---|---|
| Market cap | $23.10 B | $399.47 B |
| US-listed rank | #558 | #28 |
| Revenue (latest FY) | $3.18B | $61.16B |
| Net income (latest FY) | $1.33B | $4.23B |
| Net margin | 41.9% | 6.9% |
| P/E (trailing FY) | 17.3 | 94.5 |
| SEC filings | 4,203 | 1,008 |
AbbVie Inc. is 17.3x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($399.47 B vs $23.10 B).
In their latest fiscal years, UNITED THERAPEUTICS Corp reported $3.18B in revenue while AbbVie Inc. reported $61.16B.
Full pages: UNITED THERAPEUTICS Corp and AbbVie Inc., or browse the full rankings.